Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
Delay in interval debulking surgery after neoadjuvant chemotherapy was not found to have a significant impact on progression-free survival and overall survival in ovarian cancer cases.
Authors
- Maria Habib (ORCID: https://orcid.org/0000-0002-0152-9489)
- Kheyal Azam Khalil
- Aamir Ali Syed (ORCID: https://orcid.org/0000-0002-6504-4026)
- Abdul Wahid Anwer (ORCID: https://orcid.org/0000-0001-8737-4846)
- Afshan Saeed Usmani
- Muhammad Fahd Shah (ORCID: https://orcid.org/0000-0001-7316-9569)
Institutions
- Shaukat Khanum Memorial Cancer Hospital and Research Center (PK)
Publication Details
- Journal
- Journal of the Pakistan Medical Association
- Published
- 2025-03-20
- DOI
- https://doi.org/10.47391/jpma.20168
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00